Keros Therapeutics, Inc. (KROS)

11.71 -2.06 (-14.96%) USD  |  NASDAQ  |  Mar 05, 16:00
11.94 +0.23 (+1.96%) After-Hours: 20:00
More

Keros Therapeutics Pre-Tax Income (Quarterly)

Pre-Tax Income (Quarterly) Chart

View Pre-Tax Income (Quarterly) for KROS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Pre-Tax Income (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Pre-Tax Income (Quarterly) Range, Past 5 Years

View Pre-Tax Income (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Pre-Tax Income (Quarterly) Benchmarks

View Pre-Tax Income (Quarterly) Benchmarks
Start Trial
Amicus Therapeutics, Inc. Upgrade
MannKind Corp. Upgrade
Sarepta Therapeutics, Inc. Upgrade
Insmed, Inc. Upgrade
Ionis Pharmaceuticals, Inc. Upgrade